Cargando…

Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan

(1) Background: Previous studies showed left ventricular (LV) and left atrial (LA) improvement and reverse remodeling after therapy with Sacubitril/Valsartan (S/V) in patients affected by heart failure with reduced ejection fraction (HFrEF). Therefore, we sought to investigate predictors of LA struc...

Descripción completa

Detalles Bibliográficos
Autores principales: Correale, Michele, Magnesa, Michele, Mazzeo, Pietro, Fortunato, Martino, Tricarico, Lucia, Leopizzi, Alessandra, Mallardi, Adriana, Mennella, Raffaele, Croella, Francesca, Iacoviello, Massimo, Di Biase, Matteo, Brunetti, Natale Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917469/
https://www.ncbi.nlm.nih.gov/pubmed/36769734
http://dx.doi.org/10.3390/jcm12031086
_version_ 1784886373955665920
author Correale, Michele
Magnesa, Michele
Mazzeo, Pietro
Fortunato, Martino
Tricarico, Lucia
Leopizzi, Alessandra
Mallardi, Adriana
Mennella, Raffaele
Croella, Francesca
Iacoviello, Massimo
Di Biase, Matteo
Brunetti, Natale Daniele
author_facet Correale, Michele
Magnesa, Michele
Mazzeo, Pietro
Fortunato, Martino
Tricarico, Lucia
Leopizzi, Alessandra
Mallardi, Adriana
Mennella, Raffaele
Croella, Francesca
Iacoviello, Massimo
Di Biase, Matteo
Brunetti, Natale Daniele
author_sort Correale, Michele
collection PubMed
description (1) Background: Previous studies showed left ventricular (LV) and left atrial (LA) improvement and reverse remodeling after therapy with Sacubitril/Valsartan (S/V) in patients affected by heart failure with reduced ejection fraction (HFrEF). Therefore, we sought to investigate predictors of LA structural and functional reverse remodeling (LARR) in this setting of patients after therapy with S/V, focusing on left atrial strain parameters, such as peak atrial longitudinal strain (PALS). (2) Methods: Patients with HFrEF underwent clinical and echocardiographic evaluation at baseline and after six months of therapy with S/V. Measures of LA structure (LA volume index, LAVi) and function (LA emptying fraction (LAEF), PALS, LA conduit strain and peak atrial contraction strain (PACS) were also analyzed. Patients were divided in two groups, those with a LARR (relative reduction in LAVi > 15%, LARR+) and those without (LARR−). (3) Results: A total of 47 consecutive patients (66 ± 8 years, 85% male, mean LVEF 28 ± 6%) were enrolled in the study and followed up. A significant increase of LAEF (46 ± 13 vs. 37 ± 11%, p < 0.001) and a significant reduction of LAVi (42 ± 15 vs. 45 ± 15 mL/m(2), p = 0.008) were found after 6 months of S/V therapy; 47% of the population showed LA reverse remodeling. LA strain parameters, PALS (19 ± 8 vs. 15 ± 7 %, p < 0.001) and LA conduit (−9.7 ± 5.2% vs. −7.6 ± 4.1%, p = 0.007) significantly improved after 6 months of S/V therapy. At multivariable stepwise regression analysis, changes in LV End Diastolic Volume (LVEDV) and PALS were significantly proportional to changes in LAVi values. (4) Conclusions: Six months of treatment with S/V in patients with HFrEF was associated with an improvement in LA functional reverse remodeling in a real-world scenario. LARR was not significantly correlated to baseline echocardiographic variables, but was proportional to changes in LV volumes and LA strain parameters. Finally, after S/V therapy, a strict connection between LA and LV reverse remodeling and between LA anatomical and functional reverse remodeling seems to be outlined.
format Online
Article
Text
id pubmed-9917469
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99174692023-02-11 Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan Correale, Michele Magnesa, Michele Mazzeo, Pietro Fortunato, Martino Tricarico, Lucia Leopizzi, Alessandra Mallardi, Adriana Mennella, Raffaele Croella, Francesca Iacoviello, Massimo Di Biase, Matteo Brunetti, Natale Daniele J Clin Med Article (1) Background: Previous studies showed left ventricular (LV) and left atrial (LA) improvement and reverse remodeling after therapy with Sacubitril/Valsartan (S/V) in patients affected by heart failure with reduced ejection fraction (HFrEF). Therefore, we sought to investigate predictors of LA structural and functional reverse remodeling (LARR) in this setting of patients after therapy with S/V, focusing on left atrial strain parameters, such as peak atrial longitudinal strain (PALS). (2) Methods: Patients with HFrEF underwent clinical and echocardiographic evaluation at baseline and after six months of therapy with S/V. Measures of LA structure (LA volume index, LAVi) and function (LA emptying fraction (LAEF), PALS, LA conduit strain and peak atrial contraction strain (PACS) were also analyzed. Patients were divided in two groups, those with a LARR (relative reduction in LAVi > 15%, LARR+) and those without (LARR−). (3) Results: A total of 47 consecutive patients (66 ± 8 years, 85% male, mean LVEF 28 ± 6%) were enrolled in the study and followed up. A significant increase of LAEF (46 ± 13 vs. 37 ± 11%, p < 0.001) and a significant reduction of LAVi (42 ± 15 vs. 45 ± 15 mL/m(2), p = 0.008) were found after 6 months of S/V therapy; 47% of the population showed LA reverse remodeling. LA strain parameters, PALS (19 ± 8 vs. 15 ± 7 %, p < 0.001) and LA conduit (−9.7 ± 5.2% vs. −7.6 ± 4.1%, p = 0.007) significantly improved after 6 months of S/V therapy. At multivariable stepwise regression analysis, changes in LV End Diastolic Volume (LVEDV) and PALS were significantly proportional to changes in LAVi values. (4) Conclusions: Six months of treatment with S/V in patients with HFrEF was associated with an improvement in LA functional reverse remodeling in a real-world scenario. LARR was not significantly correlated to baseline echocardiographic variables, but was proportional to changes in LV volumes and LA strain parameters. Finally, after S/V therapy, a strict connection between LA and LV reverse remodeling and between LA anatomical and functional reverse remodeling seems to be outlined. MDPI 2023-01-30 /pmc/articles/PMC9917469/ /pubmed/36769734 http://dx.doi.org/10.3390/jcm12031086 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Correale, Michele
Magnesa, Michele
Mazzeo, Pietro
Fortunato, Martino
Tricarico, Lucia
Leopizzi, Alessandra
Mallardi, Adriana
Mennella, Raffaele
Croella, Francesca
Iacoviello, Massimo
Di Biase, Matteo
Brunetti, Natale Daniele
Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan
title Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan
title_full Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan
title_fullStr Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan
title_full_unstemmed Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan
title_short Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan
title_sort left atrial functional remodeling in patients with chronic heart failure treated with sacubitril/valsartan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917469/
https://www.ncbi.nlm.nih.gov/pubmed/36769734
http://dx.doi.org/10.3390/jcm12031086
work_keys_str_mv AT correalemichele leftatrialfunctionalremodelinginpatientswithchronicheartfailuretreatedwithsacubitrilvalsartan
AT magnesamichele leftatrialfunctionalremodelinginpatientswithchronicheartfailuretreatedwithsacubitrilvalsartan
AT mazzeopietro leftatrialfunctionalremodelinginpatientswithchronicheartfailuretreatedwithsacubitrilvalsartan
AT fortunatomartino leftatrialfunctionalremodelinginpatientswithchronicheartfailuretreatedwithsacubitrilvalsartan
AT tricaricolucia leftatrialfunctionalremodelinginpatientswithchronicheartfailuretreatedwithsacubitrilvalsartan
AT leopizzialessandra leftatrialfunctionalremodelinginpatientswithchronicheartfailuretreatedwithsacubitrilvalsartan
AT mallardiadriana leftatrialfunctionalremodelinginpatientswithchronicheartfailuretreatedwithsacubitrilvalsartan
AT mennellaraffaele leftatrialfunctionalremodelinginpatientswithchronicheartfailuretreatedwithsacubitrilvalsartan
AT croellafrancesca leftatrialfunctionalremodelinginpatientswithchronicheartfailuretreatedwithsacubitrilvalsartan
AT iacoviellomassimo leftatrialfunctionalremodelinginpatientswithchronicheartfailuretreatedwithsacubitrilvalsartan
AT dibiasematteo leftatrialfunctionalremodelinginpatientswithchronicheartfailuretreatedwithsacubitrilvalsartan
AT brunettinataledaniele leftatrialfunctionalremodelinginpatientswithchronicheartfailuretreatedwithsacubitrilvalsartan